Authorization

DGAP-News: STADA Arzneimittel Aktiengesellschaft Announcement of the Results of the Tender Offer

DGAP-News: STADA Arzneimittel AG / Key word(s): Bond


STADA Arzneimittel Aktiengesellschaft Announcement of the Results of the Tender Offer


21.06.2019 / 09:00



The issuer is solely responsible for the content of this announcement.


NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR IN OR INTO OR TO ANY PERSON LOCATED IN THE UNITED STATES.
June 21, 2019 - STADA Arzneimittel Aktiengesellschaft (the "Offeror") with its registered office at Stadastraße 2-18, 61118 Bad Vilbel, Federal Republic of Germany, hereby announces the results of its offer to purchase for cash (the "Tender Offer") any and all of its outstanding 1.750% Notes due 2022, issued on April 8, 2015 in an aggregate principal amount of EUR 300,000,000, ISIN XS1213831362, Common Code 121383136, WKN A14KJP (the "Notes") from holders of the Notes ("Noteholders"). The Tender Offer was made pursuant to the terms and conditions set out in the tender offer memorandum dated January 8, 2019 (the "Tender Offer Memorandum").

During the period from May 20, 2019, 3 pm CEST (the "Fifth Expiration Date") until June 19, 2019, 3 pm CEST (the "Final Expiration Date") Holders validly tendered Notes in an aggregate principal amount of EUR 3,040,000 for repurchase.

The Offeror hereby announces that it will accept all such Notes validly tendered as of the Final Expiration Date for repurchase under the terms and conditions set out in the Tender Offer Memorandum. The Final Payment Date (as defined in the Tender Offer Memorandum) is expected to be June 25, 2019.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Сентябрь 2020    »
ПнВтСрЧтПтСбВс
 123456
78910111213
14151617181920
21222324252627
282930